Breaking News Instant updates and real-time market news.

COH

Coach

$39.15

-0.59 (-1.48%)

, KORS

Michael Kors

$37.39

-0.44 (-1.16%)

06:45
03/21/17
03/21
06:45
03/21/17
06:45

Piper sees more accretion for Coach than Kors in Kate Spade bid

Piper Jaffray analyst Erinn Murphy sees accretion potential of 16% for Coach (COH) and 10% for Michael Kors (KORS) in potential takeovers of Kate Spade (KATE). Coach could see more backend synergies and "unique strategic optionality" as a potential suitor, but Kors is more need of growth, Murphy tells investors in a research note.

COH

Coach

$39.15

-0.59 (-1.48%)

KORS

Michael Kors

$37.39

-0.44 (-1.16%)

KATE

Kate Spade

$23.73

-0.14 (-0.59%)

COH Coach
$39.15

-0.59 (-1.48%)

02/02/17
GSCO
02/02/17
UPGRADE
GSCO
Neutral
Coach upgraded to Neutral from Sell at Goldman
Goldman analyst Lindsay Drucker Mann upgraded Coach to Neutral and raised its price target to $36 from $32 saying turnaround initiatives are working from a top-line and margin perspective, while competitors appear to be in greater "disarray." Mann sees limited multiple compression at current levels given the growth outlook.
02/02/17
02/02/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: Apple (AAPL) upgraded to Hold from Sell at BGC Financial with analyst Colin Gillis saying that while he still has issues with Apple's dependence on the iPhone he now believes that a catalyst for a meaningful pullback has passed following its earnings report, which he thinks "had plenty of chinks but did not show a meaningful decline to support a negative thesis." Gillis raised his FY17 estimates for Apple following the report and increased his price target to $125 from $85 on Apple shares. 2. Coach (COH) and lululemon (LULU) were upgraded to Neutral from Sell at Goldman. 3. Alcoa (AA) upgraded to Overweight from Neutral at JPMorgan with analyst Michael Gambardella saying the company, post the Arconic (ARNC) spin-off, is in a much better position to "weather weaker commodity price environments given the significant deleveraging of its balance sheet." Arconic absorbed most of Alcoa's consolidated debt, giving the latter "significant leverage" to recently rebounding alumina and aluminum prices, Gambardella tells investors in a research note. He raised his price target for Alcoa shares to $46 from $29. 4. U.S. Steel (X) upgraded to Buy from Neutral at BofA/Merrill with analyst Timna Tanners citing the recent pullback in shares and better outlook. 5. Foot Locker (FL) upgraded to Buy from Neutral at Guggenheim. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/13/17
BARD
02/13/17
NO CHANGE
Target $47
BARD
Outperform
Coach positive risk/reward remains, says Baird
Baird analyst Mark Altschwager fine-tuned his model for Coach to include the magnitude of calendar shifts and non-comp sales and sees a positive risk/reward as a result. The upside is supported by visible sales/margin drivers, a healthy dividend, potential M&A catalysts, and an average valuation. Altschwager reiterated his Outperform rating and $47 price target on Coach shares.
02/17/17
KEYB
02/17/17
NO CHANGE
KEYB
Kate Spade could be acquired by Coach, says KeyBanc
KeyBanc says that Coach (COH) "could make a compelling buyer" of Kate Spade (KATE), as Coach or another strategic buyer could obtain significant value from the transaction, according to the firm. The firm thinks that an acquisition of Kate Spade would raise Coach's EPS by 60c+ in the first 24 months of an acquisition, and it believes that Kate Spade could be acquired for a price in the mid-$20s per share range. KeyBanc keeps an Overweight rating on Kate Spade.
KORS Michael Kors
$37.39

-0.44 (-1.16%)

02/08/17
OPCO
02/08/17
NO CHANGE
Target $36
OPCO
Perform
Michael Kors price target lowered to $36 from $42 at Oppenheimer
Oppenheimer analyst Anna Andreeva lowered her price target for Michael Kors to $36 from $42 saying the company's Q4 guidance calls for EPS down about 25%, with comps taking another leg down as smartwatch benefit wanes after Holiday and given a bigger North America decline in wholesale. She reiterates a Perform rating on the shares.
02/07/17
COWN
02/07/17
NO CHANGE
Target $47
COWN
Market Perform
Michael Kors estimates lowered at Cowen following guidance cut
Cowen analyst Oliver Chen noted he was cautious on Michael Kors heading into its Q3 earnings report and said that caution was confirmed when the company reported lower than expected comps and guided down for both earnings and revenues. Chen expects the shares to trade lower by a mid-single digit percentage today and reiterated his Market Perform rating on Michael Kors shares, which are down about 12% to $36.20 in pre-market trading.
03/03/17
WELS
03/03/17
NO CHANGE
WELS
Fossil has 'additional red flags,' says Wells Fargo
Wells Fargo says that Fossil's (FOSL) 10K shows that the company "is generating steep losses in the U.S." Wells adds that Adidas is terminating its partnership with Fossil nine months earlier than expected, while many of Fossil's selling prices are dropping and the sales declines of its Michael Kors (KORS) brand are accelerating. Wells says that the company's U.S. issues could cause it to violate debt covenants. Wells keeps an Underperform rating on the stock.
02/07/17
JEFF
02/07/17
NO CHANGE
Target $65
JEFF
Buy
Jefferies a buyer of Michael Kors on the selloff
Jefferies analyst Randal Konik says he's a buyer of Michael Kors on today's selloff. The company, despite its moderated FY17 outlook, has a "solid strategy" in place to improve its long-term positioning, Konik tells investors in a post-earnings research note titled "When You Believe in Yourself, Buy Yourself." He believes management should buy back more shares at current levels and consider a dividend. The analyst lowered his price target for Kors to $65 from $75 and keeps a Buy rating on the name.
KATE Kate Spade
$23.73

-0.14 (-0.59%)

02/17/17
LYON
02/17/17
DOWNGRADE
Target $23
LYON
Underperform
Kate Spade downgraded to Underperform from Outperform at CLSA
CLSA analyst Rick Patel raised his price target on Kate Spade to $23 from $21 but downgraded the stock to Underperform from Outperform, stating that he benchmarks Kate with Tumi, which was acquired by Samsonite for 13.6x LTM EBITDA. He adds that he views the abbreviated conference call and lack of Q&A as signs the company is "actively in negotiations."
02/17/17
02/17/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hertz (HTZ) downgraded to Underperform from Neutral at Credit Suisse by analyst Anjaneya Singh as the analyst believes peer Avis Budget's (CAR) update presents a negative read-through for Hertz's Q4 and 2017 guidance. In an environment that presents weak volume growth, flattish pricing, and inflationary fleet costs, Singh sees Hertz struggling to generate profit growth reflected in consensus estimates. The firm also downgraded Avis Budget to Neutral from Outperform following the company's Q4 results. 2. Charter (CHTR) downgraded to Market Perform after recent rally at Telsey Advisory by analyst Tom Eagan, who has "no doubt" that the company will improve the service metrics at the legacy TWC and Bright House systems, but notes that shares have gained more than 54% since January 2016, with part of the rise fueled by speculation that Verizon (VZ) was interested in an acquisition. While unclear what Verizon's real interest is, "the possibility of a transaction is not grounds" for a multiple on Charter shares that would yield a target in the mid-$370's, Eagen tells investors. 3. Kate Spade (KATE) downgraded to Underperform from Outperform at CLSA by analyst Rick Patel, who benchmarks Kate with Tumi, which was acquired by Samsonite for 13.6x LTM EBITDA. He adds that he views the abbreviated conference call and lack of Q&A as signs the company is "actively in negotiations." 4. Advisory Board (ABCO) downgraded to Neutral from Overweight at JPMorgan by analyst Stephanie Davis, who sees the shares as fairly valued for the potential strategic alternative outcomes. The analyst sees three potential outcomes: a margin-focused restructuring, a sale to a strategic acquirer of all or part of the company, and a sale to a financial sponsor. Her analysis yields a share price range of $47-$59 for the three scenarios. 5. Hain Celestial (HAIN) downgraded to Hold from Buy at Argus by analyst John Staszak, who says that, at a minimum, Hain will have to restate its financials. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/16/17
WBLR
02/16/17
NO CHANGE
WBLR
Outperform
William Blair says $21-$29 per share 'reasonable assumption' for Kate Spade deal
William Blair analyst Dylan Carden said Kate Spade's better performance in Q4 provides potential upside to an expected takeout price and continues to see 10-14 times trailing EBITDA as "a reasonable assumption" for a potential sale. That multiple suggests a deal price of $21 to $29 per share based on 2016 EBITDA of $261M, noted Carden, who keeps an Outperform rating on Kate Spade shares.

TODAY'S FREE FLY STORIES

CNC

Centene

$74.57

-0.68 (-0.90%)

, MOH

Molina Healthcare

$66.87

-0.21 (-0.31%)

12:34
05/27/17
05/27
12:34
05/27/17
12:34
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

CNC

Centene

$74.57

-0.68 (-0.90%)

MOH

Molina Healthcare

$66.87

-0.21 (-0.31%)

HUM

Humana

$232.25

0.02 (0.01%)

AET

Aetna

$145.57

0.34 (0.23%)

ANTM

Anthem

$183.08

1.58 (0.87%)

UNH

UnitedHealth

$177.50

-0.55 (-0.31%)

WCG

WellCare

$172.97

0.15 (0.09%)

CI

Cigna

$161.32

-0.33 (-0.20%)

BX

Blackstone

$32.58

0.11 (0.34%)

NUE

Nucor

$58.15

-0.22 (-0.38%)

X

U.S. Steel

$19.74

-0.51 (-2.52%)

STLD

Steel Dynamics

$33.71

-0.73 (-2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 13

    Jun

  • 16

    Jun

21:00
05/26/17
05/26
21:00
05/26/17
21:00
General news
Breaking General news story  »

San Francisco Federal…

20:00
05/26/17
05/26
20:00
05/26/17
20:00
General news
Breaking General news story  »

San Francisco Federal…

JUNO

Juno Therapeutics

$23.30

-2.22 (-8.70%)

18:11
05/26/17
05/26
18:11
05/26/17
18:11
Hot Stocks
Juno Therapeutics director acquires 20,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

UNH

UnitedHealth

$177.50

-0.55 (-0.31%)

18:06
05/26/17
05/26
18:06
05/26/17
18:06
Hot Stocks
UnitedHealth's OptumHealth awarded $200.5M government contract »

UnitedHealth's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

VEC

Vectrus

$29.62

0.02 (0.07%)

17:56
05/26/17
05/26
17:56
05/26/17
17:56
Hot Stocks
Vectrus Systems awarded $212.03M modification to government contract »

Vectrus Systems was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMY

Imprimis

$3.34

-0.06 (-1.76%)

17:52
05/26/17
05/26
17:52
05/26/17
17:52
Syndicate
Breaking Syndicate news story on Imprimis »

Imprimis files $75M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRCP

IRSA Propiedades Comerciales

$43.58

-0.33 (-0.75%)

17:51
05/26/17
05/26
17:51
05/26/17
17:51
Syndicate
Breaking Syndicate news story on IRSA Propiedades Comerciales »

IRSA Propiedades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSKE

Daseke

$9.79

-0.11 (-1.11%)

17:44
05/26/17
05/26
17:44
05/26/17
17:44
Syndicate
Breaking Syndicate news story on Daseke »

Daseke files $300M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECYT

Endocyte

$2.47

0.02 (0.82%)

, RNN

Rexahn

$4.04

0.09 (2.28%)

17:35
05/26/17
05/26
17:35
05/26/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Endocyte (ECYT),…

ECYT

Endocyte

$2.47

0.02 (0.82%)

RNN

Rexahn

$4.04

0.09 (2.28%)

TGTX

TG Therapeutics

$12.05

0.15 (1.26%)

SGMO

Sangamo

$7.25

-0.55 (-7.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 22

    Jun

ECYT

Endocyte

$2.47

0.02 (0.82%)

17:33
05/26/17
05/26
17:33
05/26/17
17:33
Hot Stocks
Endocyte to announce updated data on EC1456, EC1169 at ASCO »

Endocyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

PEP

PepsiCo

$117.91

0.38 (0.32%)

17:30
05/26/17
05/26
17:30
05/26/17
17:30
Periodicals
PepsiCo in talks to acquire Vita Coco owner All Market, Reuters reports »

PepsiCo is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCOV

Brightcove

$6.25

0.25 (4.17%)

17:25
05/26/17
05/26
17:25
05/26/17
17:25
Hot Stocks
Breaking Hot Stocks news story on Brightcove »

ESW Capital reports 8.08%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

SHIP

Seanergy Marine

$0.69

0.001244 (0.18%)

17:19
05/26/17
05/26
17:19
05/26/17
17:19
Hot Stocks
Seanergy Marine receives Nasdaq notice »

Seanergy Maritime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$10.93

0.07 (0.64%)

, DB

Deutsche Bank

$18.46

-0.39 (-2.07%)

17:10
05/26/17
05/26
17:10
05/26/17
17:10
General news
S&P advances to end week at record as Fed signals no rush to normalize policy »

The S&P 500 (SPX)…

F

Ford

$10.93

0.07 (0.64%)

DB

Deutsche Bank

$18.46

-0.39 (-2.07%)

BBY

Best Buy

$58.97

-2.28 (-3.72%)

HPQ

HP Inc.

$18.47

0.1 (0.54%)

BX

Blackstone

$32.58

0.11 (0.34%)

NOK

Nokia

$6.38

-0.02 (-0.31%)

AAPL

Apple

$153.61

-0.26 (-0.17%)

GM

General Motors

$33.07

0.47 (1.44%)

HUN

Huntsman

$24.75

-0.11 (-0.44%)

BF.A

Brown-Forman, also tag with BFA, BFB

$52.49

-0.21 (-0.40%)

BF.B

Brown-Forman, also tag with BFA, BFB

$51.73

0.13 (0.25%)

STZ

Constellation Brands

$180.93

0.79 (0.44%)

LOW

Lowe's

$80.91

-0.42 (-0.52%)

TIF

Tiffany

$86.18

0.36 (0.42%)

SHLD

Sears

$7.78

-0.7 (-8.25%)

SIG

Signet Jewelers

$49.31

-0.99 (-1.97%)

COST

Costco

$177.86

3.13 (1.79%)

ANF

Abercrombie & Fitch

$13.22

-0.83 (-5.91%)

AEO

American Eagle

$11.50

0.08 (0.70%)

EXPR

Express

$7.85

0.03 (0.38%)

TTWO

Take-Two

$77.07

-1.46 (-1.86%)

AZO

AutoZone

$615.62

8.28 (1.36%)

DSW

DSW

$16.73

-0.06 (-0.36%)

INTU

Intuit

$138.56

0.2 (0.14%)

PBYI

Puma Biotechnology

$79.75

1.7 (2.18%)

CHS

Chico's

$9.37

-0.39 (-4.00%)

SPLS

Staples

$8.98

-0.08 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 31

    May

  • 31

    May

  • 01

    Jun

  • 01

    Jun

  • 01

    Jun

  • 02

    Jun

  • 06

    Jun

  • 06

    Jun

  • 06

    Jun

  • 07

    Jun

  • 12

    Jun

  • 12

    Jun

  • 13

    Jun

  • 20

    Jun

  • 28

    Jun

  • 21

    Jul

BGNE

BeiGene

$37.42

-0.04 (-0.11%)

17:07
05/26/17
05/26
17:07
05/26/17
17:07
Syndicate
Breaking Syndicate news story on BeiGene »

BeiGene files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 06

    Jun

CGI

Celadon Group

17:06
05/26/17
05/26
17:06
05/26/17
17:06
Hot Stocks
Breaking Hot Stocks news story on Celadon Group »

Litespeed Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRD

Crawford & Company Inc.

, CRDA

Crawford & Co.

$7.65

0.01 (0.13%)

17:05
05/26/17
05/26
17:05
05/26/17
17:05
Hot Stocks
Crawford & Company COO Robinson to leave company »

Crawford & Company…

CRD

Crawford & Company Inc.

CRDA

Crawford & Co.

$7.65

0.01 (0.13%)

CRDB

Crawford & Company

$9.08

-0.02 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEAS

SeaWorld

$18.08

-0.13 (-0.71%)

17:03
05/26/17
05/26
17:03
05/26/17
17:03
Hot Stocks
Breaking Hot Stocks news story on SeaWorld »

Hill Path Capital raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DMRC

Digimarc

$36.10

2.45 (7.28%)

17:03
05/26/17
05/26
17:03
05/26/17
17:03
Syndicate
Breaking Syndicate news story on Digimarc »

Digimarc files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 06

    Sep

IPCI

Intellipharmaceutics

$1.94

-0.01 (-0.51%)

17:01
05/26/17
05/26
17:01
05/26/17
17:01
Syndicate
Breaking Syndicate news story on Intellipharmaceutics »

Intellipharmaceutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

GWR

Genesee & Wyoming

$66.47

0.91 (1.39%)

16:57
05/26/17
05/26
16:57
05/26/17
16:57
Hot Stocks
Genesee & Wyoming CEO Hellmann named chairman of the board »

Genesee & Wyoming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZG

Paramount Gold Nevada

$1.61

0.02 (1.26%)

16:54
05/26/17
05/26
16:54
05/26/17
16:54
Syndicate
Breaking Syndicate news story on Paramount Gold Nevada »

Paramount Gold Nevada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMO

Sangamo

$7.25

-0.55 (-7.05%)

16:53
05/26/17
05/26
16:53
05/26/17
16:53
Syndicate
Breaking Syndicate news story on Sangamo »

Sangamo files $200M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

TGTX

TG Therapeutics

$12.05

0.15 (1.26%)

16:49
05/26/17
05/26
16:49
05/26/17
16:49
Syndicate
Breaking Syndicate news story on TG Therapeutics »

TG Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 22

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.